Please Wait.....
Report
France Veterinary Healthcare - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
Market Report I 2025-09-01 I 62 Pages I Mordor Intelligence
France Veterinary Healthcare Market Analysis
The France veterinary healthcare market size reached USD 2.75 billion in 2025 and is forecast to attain USD 3.78 billion by 2030, supported by a 6.61% CAGR. The market benefits from rising pet ownership, proactive livestock disease control, and rapid technology uptake across diagnostics and therapeutics. Growth concentrates in urban areas where companion animal spending climbs, while poultry health investments accelerate in rural regions. Digital tools such as AI-powered point-of-care analyzers shorten diagnosis times, and insurance uptake encourages owners to authorize advanced treatments. At the same time, veterinarian shortages outside major cities constrain service availability, prompting policy makers to subsidize rural practice and telemedicine expansion.
France Veterinary Healthcare Market Trends and Insights
Technological Advancements in Veterinary Diagnostics and Therapeutics
AI tools permeate French clinics, with 69.5% of professionals using machine-learning systems for cytology and imaging. Zoetis expanded its Vetscan Imagyst platform in 2025, enabling automated lymph-node and skin-mass review, which lifts diagnostic accuracy and cuts result turnaround to minutes. Virbac's "Day 1" mobile application allows farmers to score colostrum quality on-site, supporting neonatal immunity tracking. Large reference laboratories enhance these digital gains; Mars Petcare completed the acquisition of Cerba Vet and ANTAGENE in January 2025, adding six labs and a genetics hub to its French network. Collectively, these tools shorten treatment initiation, reduce follow-up visits, and ease the workload on an overstretched veterinarian labor force.
Rising Pet Insurance Coverage and Companion Animal Expenditure
Pet insurance penetration climbed across metropolitan France after 2024 tariff liberalization. SanteVet, Lassie, and Pety each offer plans with annual limits up to EUR 5,000 (USD 5,400), cutting out-of-pocket bills for surgeries and imaging. The share of insured dogs rose from 25% in 2024 to 32% in 2025, while cats posted a 4-percentage-point jump. Higher coverage propelled service uptake: MRI utilization grew 12% year over year, and preventive dental cleanings rose 9%. Spending aligns with a wider consumer shift toward premium veterinary nutrition, grooming, and wellness visits that keeps the France veterinary healthcare market on its growth path.
Escalating Cost of Veterinary Services and Pharmaceuticals
Base consultation fees at primary-care clinics rose from EUR 26.50 to EUR 30 (USD 32.60) in January 2025. Simultaneously, new prescription regulations moved opioids and codeine to secure pads, raising compliance overhead for practices. Consolidation contributes to tariff creep: after Mars Petcare's expansion, U.S. lawmakers cited up-charging concerns, mirroring anecdotal price increases in French urban hospitals. Livestock producers on thin margins often postpone treatments, eroding routine disease-prevention benefits.
Other drivers and restraints analyzed in the detailed report include:
Government-Led Livestock Disease Control Programs / Expansion Of E-Commerce Distribution Channels for Veterinary Products / Limited Veterinary Infrastructure in Rural Areas /
For complete list of drivers and restraints, kindly check the Table Of Contents.
Segment Analysis
Therapeutics generated 60.32% of 2024 revenue, anchoring the France veterinary healthcare market. Parasiticides and vaccines sold briskly as poultry and swine producers responded to stringent biosecurity rules, and companion-animal owners demanded broad-spectrum flea and tick solutions. Virbac's launches, including a neonatal piglet diarrhea vaccine, highlight the pace of biologic innovation. Anti-infectives face stricter antimicrobial resistance rules, yet targeted molecules still see demand during outbreaks, sustaining double-digit product turnover.
Diagnostics, while smaller, is the fastest-growing line at 7.76% CAGR. Mars Petcare's Cerba Vet acquisition multiplied laboratory throughput, and IDEXX bundled hematology and chemistry analyzers into subscription kits, lifting placement rates in independent clinics. AI algorithms embedded in handheld ultrasound and cytology readers reduce sample referrals and foster in-house revenues. The France veterinary healthcare market size for diagnostics is projected to top USD 950 million by 2030, reflecting this adoption wave.
Dogs and cats account for 45.32% of 2024 turnover, mirroring French urban demographics that support wellness plans, orthopedic surgery, and advanced imaging. Orthopedic supplement maker Vetoquinol broadened its Flexadin range in July 2025, underlining lucrative niche expansion.
Poultry, however, records the swiftest ascent with a 6.99% CAGR. Massive duck vaccination campaigns and export-oriented breeders require continuous immunization, diagnostics, and biosafety audits. The France veterinary healthcare market share for poultry health inputs is expected to pass 15% by 2030 as farmers invest in resilient production systems.
The France Veterinary Healthcare Market Report is Segmented by Product (Therapeutics and Diagnostics), Animal Type (Dogs & Cats, Horses, Ruminants, and More), Route of Administration (Oral, Parenteral, and More), End User (Veterinary Hospitals & Clinics, Reference Laboratories, and More). The Market Forecasts are Provided in Terms of Value (USD).
List of Companies Covered in this Report:
Zoetis / Boehringer Ingelheim / Ceva / Virbac / Elanco / Merck & Co., Inc. (MSD Animal Health) / IDEXX / Vetoquinol / bioMerieux / Mars Petcare (incl. VCA/Cerba Vet) / Covetrus / Dechra Pharmaceuticals / TVM Laboratoires / IVC Evidensia / Bimeda Holdings / Neogen / Henry Schein Animal Health / Innovet / Le Vet Pharma / Phileo By Lesaffre /
Additional Benefits:
The market estimate (ME) sheet in Excel format /
3 months of analyst support /
1 Introduction
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study
2 Research Methodology
3 Executive Summary
4 Market Landscape
4.1 Market Overview
4.2 Market Drivers
4.2.1 Technological Advancements in Veterinary Diagnostics and Therapeutics
4.2.2 Rising Pet Insurance Coverage and Companion Animal Expenditure
4.2.3 Government-Led Livestock Disease Control Programs
4.2.4 Expansion of E-Commerce Distribution Channels for Veterinary Products
4.2.5 Corporate Consolidation of Veterinary Clinic Networks
4.2.6 Digital Health and Remote Care Adoption in Veterinary Services
4.3 Market Restraints
4.3.1 Escalating Cost of Veterinary Services and Pharmaceuticals
4.3.2 Limited Veterinary Infrastructure in Rural Areas
4.3.3 Prevalence of Counterfeit and Substandard Medications
4.3.4 Declining Companion Animal Population Growth
4.4 Regulatory Landscape
4.5 Porter's Five Forces Analysis
4.5.1 Threat of New Entrants
4.5.2 Bargaining Power of Buyers
4.5.3 Bargaining Power of Suppliers
4.5.4 Threat of Substitute Products
4.5.5 Intensity of Competitive Rivalry
5 Market Size & Growth Forecasts (Value, USD)
5.1 By Product
5.1.1 Therapeutics
5.1.1.1 Vaccines
5.1.1.2 Parasiticides
5.1.1.3 Anti-Infectives
5.1.1.4 Medical Feed Additives
5.1.1.5 Other Therapeutics
5.1.2 Diagnostics
5.1.2.1 Immunodiagnostic Tests
5.1.2.2 Molecular Diagnostics
5.1.2.3 Diagnostic Imaging
5.1.2.4 Clinical Chemistry
5.1.2.5 Other Diagnostics
5.2 By Animal Type
5.2.1 Dogs & Cats
5.2.2 Horses
5.2.3 Ruminants
5.2.4 Swine
5.2.5 Poultry
5.2.6 Other Animal Types
5.3 By Route Of Administration
5.3.1 Oral
5.3.2 Parenteral
5.3.3 Topical
5.3.4 Other Route of Administrations
5.4 By End User
5.4.1 Veterinary Hospitals & Clinics
5.4.2 Reference Laboratories
5.4.3 Point-Of-Care / In-House Testing Settings
5.4.4 Academic & Research Institutes
6 Competitive Landscape
6.1 Market Concentration
6.2 Market Share Analysis
6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share, Products & Services, Recent Developments)
6.3.1 Zoetis Inc.
6.3.2 Boehringer Ingelheim International GmbH
6.3.3 Ceva Animal Health, Inc.
6.3.4 Virbac SA
6.3.5 Elanco Animal Health
6.3.6 Merck & Co., Inc. (MSD Animal Health)
6.3.7 IDEXX Laboratories
6.3.8 Vetoquinol SA
6.3.9 BioMerieux SA
6.3.10 Mars Petcare (incl. VCA/Cerba Vet)
6.3.11 Covetrus Inc.
6.3.12 Dechra Pharmaceuticals
6.3.13 TVM Laboratoires
6.3.14 IVC Evidensia
6.3.15 Bimeda Holdings
6.3.16 Neogen Corporation
6.3.17 Henry Schein Animal Health
6.3.18 Innovet
6.3.19 Le Vet Pharma
6.3.20 Phileo By Lesaffre
7 Market Opportunities & Future Outlook
7.1 White-Space & Unmet-Need Assessment
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security